Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2402 per EA under NDC 59746073501. Its NADAC has been published 438 times since Apr 4, 2018.
FDA first approved this application on Apr 19, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746073501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077563FDA Approved
4/19/2006
TE Code
AB
On Market Since
10/9/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 438 times since Apr 4, 2018, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2402 per EA |
|---|---|
| All-time high | $2.9863 (Oct 10, 2018) |
| All-time low | $0.2402 (Aug 19, 2026) |
| 52-week high | $0.3496 |
| 52-week low | $0.2402 |
| Median price | $1.0582 |
| Average price | $0.9595 |
| Largest weekly change | -68.4% (Oct 19, 2022) |
| Weeks tracked | 438 |
| Tracking since | Apr 4, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2402 per EA (NDC 59746073501), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 91.0%. It has been tracked across 438 weekly CMS publications since Apr 4, 2018.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Apr 4, 2018, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2402 (Aug 19, 2026) to a high of $2.9863 (Oct 10, 2018), with a median of $1.0582 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 59746073501) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.